skip to navigation skip to content
 

Associates

Back to People

Our associates offer expertise in a wide-range of professional and academic disciplines. As leaders in their field, they provide specialised knowledge and support for our startups in the form of workshops, lectures, seminars and one-to-ones.

Darren Disley

Darrin Disley

Bio

Darrin Disley is a parallel entrepreneur, angel investor and enterprise champion. He is currently CEO of Horizon Discovery Group a company he has led from a $150,000 seed funding in March 2008 to a record $113 million IPO on AIM six years later and a current market capitalisation of over $500 million. He has been involved in the startup and growth of numerous business ventures securing over $425 million business financing as well as closing over $585 million of commercial deals. In 2012, he was named Business Leader of the Year at the European Life Science Awards, in 2014 Global Executive of the Year by Scrip, in 2015 was named UK Quoted Company Entrepreneur of the Year, Cambridge Business Person of the Year, one of the 175 Faces of Chemistry by the Royal Society of Chemistry and in 2017 he was named UK Public Company. CEO of the Year at the Biotech and Money Awards Darrin supports education, entrepreneurship and mentoring programs in the UK via the Professor Christopher R Lowe Carpe Diem Enterprise Fund and has backed over 30 startup life science, technology and social enterprises. This led to him recently being conferred with a lifetime-held Queens Award for Enterprise Promotion in the 2016 birthday honours list. He is an Honorary Fellow at Cambridge Judge Business School and Enterprise Fellow at the Department of Chemical Engineering and Institute of Biotechnology both at the University of Cambridge and an Honorary Visiting Fellow at the University of Salford. He is currently Director and co-founder of Avvinity Therapeutics and GeoSpock, Chairman of Desktop Genetics, Director of Celixir and HealX, Board Member of the UK Bioindustry Association, Chairman of Trustees at Footprint Cafes CIO and serves on the advisory boards of Axol Bioscience, Biotech and Money, the Cambridge Science Centre, the Cambridge Phenomenon, Elpis Biomedical and SimPrints.

Ann Doberee

Anne Dobrée

Bio

Anne has worked in University technology commercialisation since 1999. Anne first joined the technology transfer team at the University of Cambridge in 2001, and has held a number of roles with Cambridge Enterprise and its predecessors including Head of Technology Transfer and Interim Director.

Anne joined the Seed Funds team in 2008 and was appointed Head of Seed Funds in 2011. During her time at CE, Anne has supported many early stage companies and served on the boards of Pneumacare, Cambridge CMOS Sensors, Aqdot and Cambridge Touch Technologies to name a few. Anne was a founding member of Praxis, the UK Technology Transfer Training Programme.

Away from Cambridge Enterprise, Anne has worked in technology transfer at Imperial College Innovations Limited, in pharmaceutical development at Evans Medical, and in pharmaceutical product training at Information Transfer. Anne holds a BSc in Medical Microbiology and a PhD in Immunology.

Richard Green

Richard Green

Bio

Richard Green is passionate about innovation and helping teams to turn disruptive ideas into market leading products and sustainable businesses. A founder and CEO of award winning Ubisense the world leader in Real Time Location Systems, listed on the LSE in 2011 under Richard’s leadership. Richard was a founder of Smallworld, an enterprise geospatial software company which listed on Nasdaq in 1996 and was acquired in a trade sale by GE in 2000. Richard is a Chartered Engineer, Fellow of the Institution of Mechanical Engineers and was Ernst & Young Entrepreneur of the Year 2010 Science and Technology winner. Under Richard’s leadership Ubisense was awarded multiple DTI grants, featured multiple times in the Deloitte Fast50, and was awarded both the Queen’s award for Export and Innovation. In 2011 Ubisense was technology IPO of the year, and won Business Weekly International trade award in 2013.  

Richard is engaged with early stage companies as mentor, consultant and non-executive principally in the Location, IoT, and Mobility space.

Claire Johnsen

Claire Johnsen

Bio

Claire Johnsen is an innovation specialist helping teams with ideation, being alert to trends, futures thinking, developing a value proposition which not only meets the existing, but also the future needs of their clients. Claire works as a member of the consultancy team at  St John’s Innovation Centre, Cambridge.

Pawl Piotrowicz

Pawel Piotrowicz

Bio

Pawel is a UK and European patent attorney and has nearly 20 years' experience advising on intellectual property.  He represents a wide variety of clients in the high technology sector including a significant number of start-up companies and firms based in and around Cambridge.

Pawel specialises in the fields of physics, electronics and computer software, and also in inventions which are multi-disciplinary in nature. His areas of expertise include semiconductor devices, embedded systems, power electronics, automotive electronics, nanotechnology, spintronics, printed electronics, RFID devices, telecommunications, computer networks, computer simulation, optical systems, sensors and medical devices.

In 2006, he took the lead in opening Venner Shipley’s office in Cambridge.

Pawel has been specifically singled out for recommendation in the past in the Legal 500 Directory which described him as "knowledgeable" and "hardworking". He was also commended in the 2015 edition of the Legal 500 Directory.

Tom Phillips

Tom Phillips

Bio

Tom trained in the corporate tax department of KPMG Cambridge, working on a broad range of clients from VC-backed technology companies up to multinationals. He moved over to KPMG Enterprise in 2015 to focus exclusively on startups and fast-growing technology companies, helping them with a range of tax work (including EIS and R&D tax relief) and helping them with other business concerns.  He works closely with KPMG’s High Growth Technology Group, a team based in Shoreditch working exclusively with tech startups, to help bridge the gap between Cambridge and London. 

Hitesh Sanganee

Hitesh Sanganee

AstraZeneca mentor - Director of Emerging Innovations

Bio

Dr Hitesh Sanganee is currently a Director in the Emerging Innovations group. His main role is to participate and execute the open innovation strategy within the innovative medicines function in AZ. This involves collaborating with academic institutions such as MRC (UK) NIH (US) to identify novel uses for our medicines and hence build a portfolio of projects. He has also been involved in internal ideation events (open innovation within a large company setting) in AZ.

Previously his role was in the science function within AstraZeneca. His main role was as a chemistry cluster lead inputting into external and internal drug repositioning projects and potential in-licensing projects. Other roles also have included CDL (candidate drug leader) working on regenerative medicine, and a Team Leader in the respiratory & inflammation therapeutic area. He originally received his degree and DPhil from Oxford University in chemistry and subsequently held a postdoctoral research position at Florida State University. He joined AstraZeneca as a Medicinal Chemist in 1999 conducting research within respiratory & inflammation related disease areas and has led teams to successful milestone transitions in all phases of drug discovery. He has over 40 patents and publications.

Jeremy Sosabowski

Jeremy Sosabowski

Bio

Jeremy has over a decade of business and technology commercialisation experience. His previous roles include CTO at an instrumentation company (technology acquired) and data analyst within the online transaction space. His ‘IP portfolio’ includes several granted patents and more than ten peer reviewed publications. Education: University of Cambridge Engineering PhD and Signal Processing MSc from University of Bristol.

Gordon Soutar

Gordon Soutar

Bio

Gordon is a management consultant, facilitator and entrepreneur with over 30 years experience, the last 17 with his own business, InoSens. He has worked across a broad range of industries, working with teams, to deliver innovative and practical solutions to thorny business challenges. Particular interests lie in business model and value proposition design and implementation. Gordon lives in Cambridge with his wife, two kids and three guitars.